Gentamicin-Loaded Exosomes From Immunepotent CRP Enhance Healing of Infected Diabetic Wounds in Mice

    November 2025 in “ Frontiers in Pharmacology
    Paola Leonor García Coronado, Brandon Alberto Garza Martínez, Kenia Arisbe Moreno-Amador, David Reding Hernández, Diana G. Zárate-Triviño, Diana Elia Caballero Hernández, Pablo Zapata Benavides, Gabriel Luna‐Bárcenas, Cristina Rodríguez-Padilla, Moisés Armides Franco-Molina
    New to Exosomes? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In this study, researchers found that gentamicin-loaded exosomes derived from a bovine leukocyte spleen extract significantly enhanced antimicrobial activity and tissue regeneration in infected diabetic wounds, showing potential as an effective therapeutic strategy for diabetic foot ulcers by improving infection control and promoting healing.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study investigates the use of gentamicin-loaded exosomes derived from IMMUNEPOTENT CRP to treat infected diabetic wounds in mice. The results show that these exosomes significantly enhance collagen deposition, blood vessel formation, and hair follicle regeneration, while also modulating the inflammatory response by reducing pro-inflammatory cytokines and increasing anti-inflammatory IL-10. This approach demonstrates improved antimicrobial activity and tissue regeneration, suggesting it as a promising therapeutic strategy for diabetic foot ulcers by effectively combining infection control with regenerative and immunomodulatory effects.
    Discuss this study in the Community →